Analysis of embryo-derived factors as markers of developmental potential and viability

Human Assisted Reproductive Technology: Future Trends in Laboratory and Clinical Practice

Volumn , Issue , 2011, Pages 278-288

  O’Neill, Chris ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901640752     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511734755.026     Document Type: Chapter

References (77)

1. Morton H, Hegh V, Clunie GJA. Studies of the rosette inhibition test in pregnant mice: evidence of immunosuppression? Proc R Soc Lond 1976;193:413–19.
2. Cavanagh AC, Morton H, Rolfe BE, Gidley-Baird AA. Ovum factor: a first signal of pregnancy? Am J Reprod Immunol 1992; 2: 97–101.
3. Orozco C, Cock I, Perkins AV, Clarke FM. Platelet activating factor and serum components from oestrous mice co-operate to mimic the activity of ‘early pregnancy factor’ in the rosette inhibition assay. J Reprod Fertil 1990;88:447–57.
4. O’Neill C. Thrombocytopenia is a initial maternal response to fertilisation in mice. J Reprod Fertil 1985;73:559–66.
5. O’Neill C. Examination of the causes of early pregnancy associated thrombocytopenia in mice. J Reprod Fertil 1985;73:567–77.
6. O’Neill C. Partial characterisation of the embryoderived platelet activating factor in mice. J Reprod Fertil 1985;75:375–80.
7. O’Neill C. The role of paf in embryo physiology. Hum Reprod Update 2005;11:215–28.
8. Collier M, O’Neill C, Ammit AJ, Saunders DM. Biochemical and pharmacological characterisation of human embryo-derived platelet activating factor. Hum Reprod 1988;3:993–8.
9. O’Neill C. Evidence for the requirement of autocrine growth factors for development of mouse preimplantation embryos in vitro. Biol Reprod 1997;56:229–37.
10. O’Neill C. Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. Biol Reprod 1998;58:1303–9.
11. Rappolee DA, Brenner CA, Schultz R, Mark D, Werb Z. Developmental expression of PDGF, TGF-a and TGF-b genes in preimplantation mouse embryos. Science 1988;241:1823–5.
12. Hardy K, Spanos S. Growth factor expression and function in the human and mouse preimplantation embryo. J Endocrin 2002;172:221–36.
13. Paria BC, Dey SK. Preimplantation embryo development in vitro: cooperative interactions among embryos and the role of growth factors. Proc Natl Acad Sci U S A 1990;87:4756–60.
14. Lane M, Gardner DK. Effect of incubation volume and embryo density on the development and viability of mouse embryos in vitro. Hum Reprod 1992;7:558–62.
15. Ryan JP, O’Neill C, Wales RG. Oxidative metabolism of energy substrates by preimplantation mouse embryos in the presence of platelet-activating factor. J Reprod Fertil 1990;89:301–7.
16. Ryan JP, Spinks NR, O’Neill C, Wales RG. Implantation potential and fetal viability of mouse embryos cultured in media supplemented with platelet activating factor. J Reprod Fertil 1990;89:309–15.
17. O’Neill C, Ryan JP, Collier M, et al. Supplementation of IVF culture media with platelet activating factor (PAF) increased the pregnancy rate following embryo transfer. Lancet 1989;ii:769–72.
18. O’Neill C, Ryan JP, Collier M, et al. Outcome of pregnancies resulting from a trial of supplementing human IVF culture media with platelet-activating factor. Reprod Fertil Dev 1992;4:109–12.
19. Lighten AD, Moore GE, Winston RM, Hardy K. Routine addition of human insulin-like growth factor-I ligand could benefit clinical in-vitro fertilization culture. Hum Reprod 1998;13:3144–50.
20. Sargent L, Martin KL, Barlow DH. The use of recombinant growth factors to promote human embryo development in serum-free medium. Hum Reprod Update 1998;13:239–48.
21. Lédée-Bataille N, Laprée-Delage G, Taupin JL, et al. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2002;17:213–18.
22. Katz-Jaffe MG, Schoolcraft WB, Gardner DK. Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertil Steril 2006;86:678–85.
23. Beardsley A, Li Y, O’Neill C. Characterization of a diverse secretome generated by the mouse preimplantation embryo in vitro. Reprod Biol Endocrinol 2010;8:71.
24. Roussev RG, Barnea ER, Thomason EJ, Coulam CB. A novel bioassay for detection of preimplantation factor (PIF). Am J Reprod Immunol 1995;33:68–73.
25. Carosellaa ED, HoWangYina K, Faviera B, LeMaoult J. HLA-G-dependent suppressor cells: Diverse by nature, function, and significance. Hum Immunol 2008;69:700–7.
26. Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci U S A 1996;93:161–5.
27. Menicucci A, Noci I, Fuzzi B, et al. Non-classic sHLA class I in human oocyte culture medium. Hum Immunol 1999;60:1054–7.
28. Lu DP, Tian L, O’Neill C, King NJC. Regulation of expression of CAMs in murine oocytes, periimplantation and post-implantation embryos. Cell Res 2002;12:373–83.
29. Borgatti M, Rizzo R, Canto MBD, et al. Release of sICAM-1 in oocytes and in vitro fertilized human embryos. PLoS ONE 2008;3:e3970.
30. Ammit AJ, O’Neill C. The role of albumin in the release of platelet-activating factor by mouse preimplantation embryos in vitro. J Reprod Fertil 1997;109:309–18.
31. Bratton DL. Release of platelet activation factor from activated neutrophils. Transglutaminase-dependent enhancement of transbilayer movement across the plasma membrane. J Biol Chem 1993;268:3364–73.
32. Ernest S, Bello-Reuss E. Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells. J Am Soc Nephrol 1999;10:2306–13.
33. Raggers RJ, Vogels I, van Meer G. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem J 2001;357:859–65.
34. Kantar A, Giorgi PL, Fiorini R. Effect of PAF on human lymphocyte membranes: a fluorescence study. Agents Actions 1993;38:C115–18.
35. Kramp W, Pieroni G, Pinckard RN, Hanahan DJ. Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs. Chem Phys Lipids 1984;35:49–62.
36. Ammit AJ, O’Neill C. Studies of the nature of the binding by albumin of platelet-activating factor released from cells. J Biol Chem 1997;272:18772–8.
37. Stojanov T, O’Neill C. Ontogeny of expression of a receptor for platelet-activating factor in mouse preimplantation embryos and the effects of fertilisation and culture in vitro. Biol Reprod 1999;60:674–82.
38. Stojanov T, Alechna S, O’Neill C. In vitro fertilisation and culture of embryos in vitro significantly retards the onset of synthesis of IGF-II ligand from the zygotic genome. Mol Hum Reprod 1999;5:116–24.
39. Stojanov T, O’Neill C. In vitro fertilization causes epigenetic modifications to the onset of gene expression from the zygotic genome in mice. Biol Reprod 2001;64:696–705.
40. Emerson M, Travis AR, Bathgate R, et al. Characterization and functional significance of calcium transients in the 2-cell mouse embryo induced by an autocrine growth factor. J Biol Chem 2000;275:21905–13.
41. Li Y, Day ML, O’Neill C. Autocrine activation of ion currents in the two-cell mouse embryo. Exp Cell Res 2007;313:2786–94.
42. Li Y, O’Neill C, Day MI. Activation of a chloride channel by a trophic ligand is required for development of the mouse pre-implantation embryo in vitro. Biol Reprod 2009;81:759–67.
43. Jin XL, O’Neill C. The presence and activation of two essential transcription factors (cAMP response element-binding protein and cAMP-dependent transcription factor ATF1) in the two-cell mouse embryo. Biol Reprod 2010;82:459–68.
44. Jin XL, Chandrakanthan V, Morgan HD, O’Neill C. Preimplantation embryo development in the mouse requires the latency of TRP53 expression, which is induced by a ligand-activated PI3 kinase/AKT/MDM2- mediated signaling pathway. Biol Reprod 2009;80:286–94.
45. O’Neill C. Phosphatidylinositol 3-kinase signaling in mammalian preimplantation embryo development. Reproduction 2008;136:147–56.
46. Warner CM, Brownell MS, Rothschild MF. Analysis of litter size and weight in mice differing in Ped gene phenotype and the Q region of the H-2 complex. J Reprod Immunol 1991;19:303–13.
47. Tian Z, Xu Y, Warner CM. Removal of Qa-2 antigens alters the Ped gene phenotype of preimplantaion mouse embryos. Biol Reprod 1992;47:271–6.
48. Comiskeya M, Goldsteina CY, De Fazioa SR, et al. Evidence that HLA-G is the functional homolog of mouse Qa-2, the ped gene product. Hum Immunol 2003;64:999–1004.
49. Yao YQ, Barlow DH, Sargent IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 2005;175:8379–85.
50. Comiskey M, Domino KE, Warner CM. HLA-G is found in lipid rafts and can act as a signaling molecule. Hum Immunol 2007;68:1–11.
51. Byrne MJ, Warner CM. MicroRNA expression in preimplantation mouse embryos from Ped gene positive compared to Ped gene negative mice. J Assist Reprod Gen 2008;25:205–14.
52. Martí S, Ten J, Marcos P, et al. Quantifying soluble HLA-G in supernatants of cultured embryos as a marker of implantation potential in an assisted reproduction program. Immunología 2007;26:127–34.
53. Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. Reprod Biomed Online 2006;13:272–7.
54. Purnell ET, Warner CM, Kort HI, et al. Influence of the preimplantation embryo development (Ped) gene on embryonic platelet-activating factor (PAF) levels. J Assist Reprod Gen 2006;23:269–73.
55. O’Neill C, Gidley-Baird AA, Pike IL, Saunders DM. Use of a bio-assay for embryo-derived platelet activating factor as a means of assessing quality and pregnancy potential of human embryos. Fertil Steril 1987;47:969–75.
56. Collier M, O’Neill C, Ammit AJ, Saunders DM. Measurement of human embryo-derived plateletactivating factor (PAF) using a quantitative bioassay of platelet aggregation. Hum Reprod 1990;5:323–8.
57. Ammit AJ, O’Neill C. Comparison of a radioimmunoassay and bioassay for embryo-derived platelet-activating factor. Hum Reprod 1991;6:872–8.
58. Roudebush WE, Wininger JD, Jones AE, et al. Embryonic platelet-activating factor: an indicator of embryo viability. Hum Reprod 2002;17:1306–10.
59. Nakatsuka M, Yoshida N, Kudo T. Platelet activating factor in culture media as an indicator of human embryonic development after in-vitro fertilization. Hum Reprod 1992;7:1435–9.
60. Amiel ML, Duquenne C, Benveniste J, Testart J. Platelet aggregating activity in human embryo culture media free of PAF-acether. Hum Reprod 1989;4:327–30.
61. Smal MA, Dziadek M, Cooney SJ, Attard M, Baldo BA. Examination for platelet-activating factor production by preimplantation mouse embryos using a specific radioimmunoassay. J Reprod Fertil 1990;90:419–25.
62. Sageshima N, Shobu T, Awai K, et al. Soluble HLA-G is absent from human embryo cultures: A reassessment of sHLA-G detection methods. J Reprod Immunol 2007;75:11–22.
63. Rebmann V, Switala M, Eue I, et al. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum Immunol 2007;68:251–8.
64. Vercammen MJ, Verloes A, Van de Velde H, Haentjens P. Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum Reprod Update 2008;14:209–18.
65. Shaikly V, Morrison I, Taranissi M, et al. Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression. J Immunol 2008; 180:4330–7.
66. Tabiasco J, Perrier d’Hauterive S, Thonon F, et al. Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre study. Reprod Biomed Online 2009;18:374–81.
67. Stokes PJ, Abeydeera LR, Leese HJ. Development of porcine embryos in vivo and in vitro; evidence for embryo ‘cross talk’ in vitro. Dev Biol 2005;284:62–71.
68. Almagor M, Bejar C, Kafka I, Yaffe H. Pregnancy rates after communal growth of preimplantation human embryos in vitro. Fertil Steril 1996;66:394–7.
69. Moessner J, Dodson WC. The quality of human embryo growth is improved when embryos are cultured in groups rather than separately. Fertil Steril 1995;64:1034–5.
70. Gardner DK, Pool TB, Lane M. Embryo nutrition and energy metabolism and its relationship to embryo growth, differentiation, and viability. Semin Reprod Med 2000;18:205–18.
71. O’Neill C. The potential roles for embryotrophic ligands in preimplantation embryo development. Hum Reprod Update 2008;14: 275–88.
72. Gardner DK, Lane M. Amino acids and ammonium regulate mouse embryo development in culture. Biol Reprod 1993;48:377–85.
73. Warner CM, Panda P, Almquist CD, Xu Y. Preferential survival of mice expressing the Qa-2 antigen. J Reprod Fertil 1993;99:145–7.
74. Watkins A, Wilkins A, Osmond C, et al. The influence of mouse Ped gene expression on postnatal development. J Physiol 2006;571:211–20.
75. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307–10.
76. Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995;378:203–5.
77. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1–7.